Page 58 - Read Online
P. 58

Review Article



           Targeting glioma stem cells via the Hedgehog

           signaling pathway



           Yang Liu, Xing Liu, Ling‑Chao Chen, Wen‑Zhong Du, Yu‑Qiong Cui, Xing‑Yin Piao, Yong‑Li Li, Chuan‑Lu Jiang
           Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, Heilongjiang, China.


                                                   ABSTRA CT
            Cancer is one of the leading causes of death worldwide. Gliomas are among the most devastating tumor types, and current clinical
            therapies are unsatisfactory. Recent reports revealed the importance of glioma‑propagating cells in the malignancy of gliomas. These
            cells, also referred to as glioma stem cells (GSCs), share similarities with neural stem cells (NSCs). The Hedgehog (Hh) signaling
            pathway controls tissue polarity, patterning maintenance, and maintenance of NSCs during embryonic development. Aberrant
            activation of the Hh pathway resulting from mutation and deregulation has recently been recognized to cause tumorigenesis in a
            wide variety of tissues, including gliomas and GSCs. In this review, we explore the role of the Hh signaling pathway in GSCs and
            its potential as a therapeutic strategy.

            Key words: Cancer stem cells, glioma, Hedgehog, microRNA



           INTRODUCTION                                       and maintenance of glioma stem cells (GSCs).  Since
                                                                                                       [4]
                                                              GSCs are important biological factors responsible
           Cancer is estimated to be the leading cause of death   for cancer invasion, metastasis, drug resistance, and
           worldwide by the World Health Organization (WHO).    relapse, Hh signaling is believed to be an important
                                                         [1]
           Gliomas are one of the most lethal adult brain tumors.   target for cancer therapy. Recently, both natural and
           Although substantial progress has been made, there   synthesized small-molecule inhibitors of Hh signaling
           is still a lack of effective therapy. It is reported that   have been investigated as potential cancer treatments.
           patients with low-grade gliomas can survive for years,   However, targeting only one molecule may be
           while patients with glioblastoma  (WHO grade  IV)   insufficient. Therefore, strategies using a combination
           survive for only 1-2 years after diagnosis. [2]    of  natural  products  and  chemotherapeutics  with
                                                              different targets may improve the overall survival of
           Tumors are composed of a heterogeneous group of    patients with gliomas.
           cells. Some tumor cell fractions have the ability to
           initiate tumors in xenograft models, whereas other   CANCER STEM CELLS IN GLIOMA
           fractions do not.  These cells, capable of sphere-like
                          [3]
           growth in vitro and tumor formation in vivo, are defined   Cancer stem cells and the niche
           as  cancer  stem  cells  (CSCs)  and share  similarities   The concept of CSCs has been in use for over 50 years.
           with normal neural stem cells (NSCs). It has been   In the 1990s, Lapidot et al.  identified leukemia stem
                                                                                      [5]
           hypothesized that these cells are involved in radio- and   cells capable of generating human acute myeloid
           chemo-resistance, as well as tumor recurrence.     leukemia after transplantation. Within gliomas, stem-
                                                              like cells with the ability to self-renew, differentiate
           The Hedgehog (Hh) signaling pathway plays a pivotal   into multiple lineages, and initiate tumors are known as
           role in embryonic development, including the formation   GSCs. Subsequently, GSCs capable of self-renewal and
                                                              producing glioma-initiating cells were identified using
                          Access this article online          a limiting dilution analysis.  The presence of GSCs and
                                                                                      [6]
               Quick Response Code:                           the increasing evidence of radio-resistance and chemo-
                                    Website:                  resistance indicated that GSCs may contribute to tumor
                                    www.nnjournal.net
                                                              maintenance and recurrence, and that targeting GSCs
                                    DOI:                      may be a promising therapeutic intervention. [7,8]  Stem
                                    10.4103/2347-8659.139715   cells reside in specialized niches, which could regulate
                                                              their proliferation and differentiation.  More than one
                                                                                                [9]
           Corresponding Author: Dr. Chuan‑Lu Jiang, Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical
           University, No. 246 Xuefu Road, Nangang, Harbin 150086, Heilongjiang, China. E‑mail: jcl6688@163.com



          Neuroimmunol Neuroinflammation | Volume 1 | Issue 2 | September 2014                              51
   53   54   55   56   57   58   59   60   61   62   63